| NCT01780753 | Vivax Malaria | Drug: Primaquine | University of Oxford | Phase 1 | 2012-12-01 | 2016-02-12 |
| NCT02898779 | Malaria | Drug: Primaquine, R-Primaquine, S-Primaquine, SR Primaquine | University of Mississippi, Oxford | Phase 1 | 2017-02-01 | 2017-02-10 |
| NCT02789566 | Obese | Drug: Primaquine | University of Oxford | Phase 1 | 2011-08-01 | 2016-06-01 |
| NCT02535767 | Malaria | Drug: Primaquine | University of California, San Francisco|Malaria Research and Training Center, Bamako, Mali|Radboud University|University of Mississippi Medical Center|Bill and Melinda Gates Foundation | Phase 1|Phase 2 | 2015-08-01 | 2017-02-02 |
| NCT01365598 | Falciparum Malaria | Drug: Primaquine | London School of Hygiene and Tropical Medicine|Wellcome Trust | Phase 3 | 2011-12-01 | 2013-06-11 |
| NCT02364583 | Plasmodium Vivax | Drug: Primaquine | Papua New Guinea Institute of Medical Research|Walter and Eliza Hall Institute of Medical Research|The University of Western Australia|University of Oxford|Curtin University | Phase 4 | 2010-06-01 | 2015-10-12 |
| NCT01668433 | G6PD Normal|G6PD Deficient|Healthy | Drug: Regimens (Primaquine, Methylene blue) | University of Oxford | Phase 1 | 2013-07-01 | 2015-11-02 |
| NCT02793388 | Malaria | Drug: Supervised primaquine treatment|Drug: Unsupervised primaquine treatment | Menzies School of Health Research|Armauer Hansen Research Institute, Ethiopia | Phase 4 | 2016-09-01 | 2017-02-07 |
| NCT01552330 | Healthy | Drug: Primaquine and Pyronaridine-artesunate|Drug: Primaquine and Pyronaridine-Artesunate | University of Oxford | Phase 1 | 2012-05-01 | 2013-08-27 |
| NCT01716260 | Vivax Malaria | Drug: Chloroquine|Drug: Primaquine | Menzies School of Health Research|Ministry of Health, Bhutan | | 2013-01-01 | 2016-05-26 |
| NCT02960568 | Pharmacologic Action | Drug: Primaquine | Walter Reed Army Institute of Research (WRAIR) | Phase 1 | 2016-01-01 | 2016-11-08 |
| NCT02691910 | Malaria, Vivax | Drug: Chloroquine|Drug: Primaquine | Oswaldo Cruz Foundation|University of Sao Paulo | Phase 2|Phase 3 | 2014-08-01 | 2016-02-24 |
| NCT01849640 | Uncomplicated Plasmodium Falciparum Malaria | Drug: DHA-piperaquine and Primaquine | David Saunders|National Centre for Parasitology, Entomology and Malaria Control, Cambodia|Royal Cambodian Armed Forces|US Department of Defense Armed Forces Health Surveillance Center|Armed Forces Research Institute of Medical Sciences, Thailand | | 2012-12-01 | 2015-07-13 |
| NCT02090036 | Plasmodium Falciparum | Drug: Primaquine (For artemether-lumefantrine+primaquine arm)|Drug: Placebo (For artemether-lumefantrine arm) | Muhimbili University of Health and Allied Sciences|Karolinska Institutet | Phase 4 | 2014-07-01 | 2014-12-05 |
| NCT02434952 | Malaria, Falciparum|G6PD Deficiency | Drug: Dihydroartemisinin piperaquine (DHA PP)|Drug: Primaquine | Malaria Consortium|National Centre for Parasitology, Entomology and Malaria Control, Cambodia|Institute Pasteur, Cambodia|World Health Organization|Centers for Disease Control and Prevention | Phase 4 | 2014-10-01 | 2016-08-22 |
| NCT01525511 | Healthy | Drug: A|Drug: B | University of Oxford | Phase 1 | 2012-06-01 | 2013-08-27 |
| NCT01288820 | Vivax Malaria | Drug: Dihydroartemisinin/piperaquine + primaquine|Drug: Artesunate-amodiaquine + primaquine | University of Oxford|Mahidol University|Ministry of Health, Indonesia | Phase 3 | 2011-01-01 | 2013-08-28 |
| NCT01935882 | Malaria|Asymptomatic Malaria|Plasmodium Falciparum | Drug: Artemether-lumefantrine combination|Drug: Artemether-Lumefantrine with a single dose of 0.25mg/kg primaquine|Drug: Artemether-Lumefantrine with a single dose of 0.4mg/kg primaquine | London School of Hygiene and Tropical Medicine|Radboud University|Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso | Phase 2|Phase 3 | 2013-09-01 | 2015-09-01 |
| NCT01837992 | Malaria | Drug: Primaquine|Drug: delayed primaquine | Menzies School of Health Research|Walter and Eliza Hall Institute of Medical Research|Ministry of Health, Vanuatu|Ministry of Health, Solomon Islands|World Health Organization | | 2013-05-01 | 2013-11-07 |
| NCT00158587 | Malaria|Vivax Malaria | Drug: primaquine | London School of Hygiene and Tropical Medicine|HealthNet TPO | Phase 3 | 2004-04-01 | 2017-01-11 |
| NCT02876549 | Vivax Malaria | Drug: Chloroquine|Drug: Primaquine 0.25 mg/kg/day|Drug: Primaquine 0.75 mg/kg weekly | University of Oxford|Mahidol Oxford Tropical Medicine Research Unit|Nangarhar University, Afghanistan | Phase 4 | 2016-08-01 | 2016-08-22 |
